IN8bio, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 7.53 million compared to USD 6.15 million a year ago. Basic loss per share from continuing operations was USD 0.3 compared to USD 0.33 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 USD | 0.00% | +0.97% | -24.64% |
Apr. 10 | Top Premarket Gainers | MT |
Apr. 10 | North American Morning Briefing: Traders Await the CPI Report | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.64% | 45.02M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- INAB Stock
- News IN8bio, Inc.
- IN8bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023